Study design

randomized, controlled, single-blinded study

Country

Denmark

Object

men > 18 years who were scheduled for RARP

Inclusion criteria

estimated glomerular fltration rate < 15 ml/min, body mass index > 35 kg/m2, previous lung surgery (any), known lung disease requiring pharmacological treatment, known severe cardiac disease defned as New Work Heart Association class III or above, acute myocardial infarction within the last 12 months before the surgery, and neuromuscular illness

Sample size

24

Topic classification

Intraoperative operation

Keypoint

No evidence of lung protective effects of lung protective ventilation compared to conventiol ventilation estimated by pulmory function tests, IL-6 levels and postoperative complications in patients undergoing RARP.

Year